NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Bloomberg story promotes “obesity cure”

Posted By

Tags

In what is becoming a race for the bottom of health news stories, a recent Bloomberg story on Boston.com is headlined:

“Lose weight forever with Abiliti implant as obesity cure.” 

Lose weight forever?

Obesity cure?

Excerpt from the   advertisement- , er, story:

“Long-term results from studies on Abiliti are not yet available. So far, a 12-month study concluded in March of 25 participants showed an average total loss of 14 kilograms and a 30 percent drop in excess weight, or the amount above ideal body weight.”

25 people?

Only at the very end of the story do we hear:

“There’ve been a lot of electric stimulation devices that have failed to show any advantage over placebo” or other weight-loss surgeries, Cleveland Clinic’s Schauer said.

Wow.

Maybe we need to start reviewing Bloomberg pieces on a regular basis.  Look at how many other websites picked up this headline and ran with it.

 

 

 

You might also like

Comments

Please note, comments are no longer published through this website. All previously made comments are still archived and available for viewing through select posts.

Comments are closed.